 | • レポートコード：QYR2104Z1710 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ダクチノマイシンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、インプラント）、用途別市場規模（アルキル化剤、ホルモン、植物薬）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ダクチノマイシンの市場動向 ・企業の競争状況、市場シェア ・ダクチノマイシンの種類別市場規模（注射、インプラント） ・ダクチノマイシンの用途別市場規模（アルキル化剤、ホルモン、植物薬） ・ダクチノマイシンの北米市場規模2016-2027（アメリカ、カナダ） ・ダクチノマイシンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ダクチノマイシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ダクチノマイシンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ダクチノマイシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、GSK、Recordati Rare Diseases、Lundbeck、Merck、Prasco Laboratories、X-GEN Pharmaceuticals、Mylan Institutional、Bedford Pharmaceuticals、HISUN、Hainan Jinrui Pharmaceutical、Qilu Pharmaceutical、Shanghai Zhongke Pharmaceutical、Shanghai Xinya Pharmaceutical、Nantong Xinhe Biotechnology） ・結論 |
Dactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin’s disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.
Market Analysis and Insights: Global Dactinomycin Market
The global Dactinomycin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dactinomycin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dactinomycin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dactinomycin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dactinomycin market.
Global Dactinomycin Scope and Market Size
Dactinomycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dactinomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Implants
Segment by Application
Alkylating Agent
Hormone
Plant Medicine
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
GSK
Recordati Rare Diseases
Lundbeck
Merck
Prasco Laboratories
X-GEN Pharmaceuticals
Mylan Institutional
Bedford Pharmaceuticals
HISUN
Hainan Jinrui Pharmaceutical
Qilu Pharmaceutical
Shanghai Zhongke Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dactinomycin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Implants
1.3 Market by Application
1.3.1 Global Dactinomycin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Alkylating Agent
1.3.3 Hormone
1.3.4 Plant Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dactinomycin Market Perspective (2016-2027)
2.2 Dactinomycin Growth Trends by Regions
2.2.1 Dactinomycin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dactinomycin Historic Market Share by Regions (2016-2021)
2.2.3 Dactinomycin Forecasted Market Size by Regions (2022-2027)
2.3 Dactinomycin Industry Dynamic
2.3.1 Dactinomycin Market Trends
2.3.2 Dactinomycin Market Drivers
2.3.3 Dactinomycin Market Challenges
2.3.4 Dactinomycin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dactinomycin Players by Revenue
3.1.1 Global Top Dactinomycin Players by Revenue (2016-2021)
3.1.2 Global Dactinomycin Revenue Market Share by Players (2016-2021)
3.2 Global Dactinomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dactinomycin Revenue
3.4 Global Dactinomycin Market Concentration Ratio
3.4.1 Global Dactinomycin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dactinomycin Revenue in 2020
3.5 Dactinomycin Key Players Head office and Area Served
3.6 Key Players Dactinomycin Product Solution and Service
3.7 Date of Enter into Dactinomycin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dactinomycin Breakdown Data by Type
4.1 Global Dactinomycin Historic Market Size by Type (2016-2021)
4.2 Global Dactinomycin Forecasted Market Size by Type (2022-2027)
5 Dactinomycin Breakdown Data by Application
5.1 Global Dactinomycin Historic Market Size by Application (2016-2021)
5.2 Global Dactinomycin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Dactinomycin Market Size (2016-2027)
6.2 North America Dactinomycin Market Size by Type
6.2.1 North America Dactinomycin Market Size by Type (2016-2021)
6.2.2 North America Dactinomycin Market Size by Type (2022-2027)
6.2.3 North America Dactinomycin Market Size by Type (2016-2027)
6.3 North America Dactinomycin Market Size by Application
6.3.1 North America Dactinomycin Market Size by Application (2016-2021)
6.3.2 North America Dactinomycin Market Size by Application (2022-2027)
6.3.3 North America Dactinomycin Market Size by Application (2016-2027)
6.4 North America Dactinomycin Market Size by Country
6.4.1 North America Dactinomycin Market Size by Country (2016-2021)
6.4.2 North America Dactinomycin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Dactinomycin Market Size (2016-2027)
7.2 Europe Dactinomycin Market Size by Type
7.2.1 Europe Dactinomycin Market Size by Type (2016-2021)
7.2.2 Europe Dactinomycin Market Size by Type (2022-2027)
7.2.3 Europe Dactinomycin Market Size by Type (2016-2027)
7.3 Europe Dactinomycin Market Size by Application
7.3.1 Europe Dactinomycin Market Size by Application (2016-2021)
7.3.2 Europe Dactinomycin Market Size by Application (2022-2027)
7.3.3 Europe Dactinomycin Market Size by Application (2016-2027)
7.4 Europe Dactinomycin Market Size by Country
7.4.1 Europe Dactinomycin Market Size by Country (2016-2021)
7.4.2 Europe Dactinomycin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Dactinomycin Market Size (2016-2027)
8.2 Asia-Pacific Dactinomycin Market Size by Type
8.2.1 Asia-Pacific Dactinomycin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dactinomycin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dactinomycin Market Size by Type (2016-2027)
8.3 Asia-Pacific Dactinomycin Market Size by Application
8.3.1 Asia-Pacific Dactinomycin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dactinomycin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dactinomycin Market Size by Application (2016-2027)
8.4 Asia-Pacific Dactinomycin Market Size by Region
8.4.1 Asia-Pacific Dactinomycin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dactinomycin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dactinomycin Market Size (2016-2027)
9.2 Latin America Dactinomycin Market Size by Type
9.2.1 Latin America Dactinomycin Market Size by Type (2016-2021)
9.2.2 Latin America Dactinomycin Market Size by Type (2022-2027)
9.2.3 Latin America Dactinomycin Market Size by Type (2016-2027)
9.3 Latin America Dactinomycin Market Size by Application
9.3.1 Latin America Dactinomycin Market Size by Application (2016-2021)
9.3.2 Latin America Dactinomycin Market Size by Application (2022-2027)
9.3.3 Latin America Dactinomycin Market Size by Application (2016-2027)
9.4 Latin America Dactinomycin Market Size by Country
9.4.1 Latin America Dactinomycin Market Size by Country (2016-2021)
9.4.2 Latin America Dactinomycin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dactinomycin Market Size (2016-2027)
10.2 Middle East & Africa Dactinomycin Market Size by Type
10.2.1 Middle East & Africa Dactinomycin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dactinomycin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dactinomycin Market Size by Type (2016-2027)
10.3 Middle East & Africa Dactinomycin Market Size by Application
10.3.1 Middle East & Africa Dactinomycin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dactinomycin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dactinomycin Market Size by Application (2016-2027)
10.4 Middle East & Africa Dactinomycin Market Size by Country
10.4.1 Middle East & Africa Dactinomycin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dactinomycin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Dactinomycin Introduction
11.1.4 AstraZeneca Revenue in Dactinomycin Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dactinomycin Introduction
11.2.4 GSK Revenue in Dactinomycin Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Recordati Rare Diseases
11.3.1 Recordati Rare Diseases Company Details
11.3.2 Recordati Rare Diseases Business Overview
11.3.3 Recordati Rare Diseases Dactinomycin Introduction
11.3.4 Recordati Rare Diseases Revenue in Dactinomycin Business (2016-2021)
11.3.5 Recordati Rare Diseases Recent Development
11.4 Lundbeck
11.4.1 Lundbeck Company Details
11.4.2 Lundbeck Business Overview
11.4.3 Lundbeck Dactinomycin Introduction
11.4.4 Lundbeck Revenue in Dactinomycin Business (2016-2021)
11.4.5 Lundbeck Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Dactinomycin Introduction
11.5.4 Merck Revenue in Dactinomycin Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Prasco Laboratories
11.6.1 Prasco Laboratories Company Details
11.6.2 Prasco Laboratories Business Overview
11.6.3 Prasco Laboratories Dactinomycin Introduction
11.6.4 Prasco Laboratories Revenue in Dactinomycin Business (2016-2021)
11.6.5 Prasco Laboratories Recent Development
11.7 X-GEN Pharmaceuticals
11.7.1 X-GEN Pharmaceuticals Company Details
11.7.2 X-GEN Pharmaceuticals Business Overview
11.7.3 X-GEN Pharmaceuticals Dactinomycin Introduction
11.7.4 X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2016-2021)
11.7.5 X-GEN Pharmaceuticals Recent Development
11.8 Mylan Institutional
11.8.1 Mylan Institutional Company Details
11.8.2 Mylan Institutional Business Overview
11.8.3 Mylan Institutional Dactinomycin Introduction
11.8.4 Mylan Institutional Revenue in Dactinomycin Business (2016-2021)
11.8.5 Mylan Institutional Recent Development
11.9 Bedford Pharmaceuticals
11.9.1 Bedford Pharmaceuticals Company Details
11.9.2 Bedford Pharmaceuticals Business Overview
11.9.3 Bedford Pharmaceuticals Dactinomycin Introduction
11.9.4 Bedford Pharmaceuticals Revenue in Dactinomycin Business (2016-2021)
11.9.5 Bedford Pharmaceuticals Recent Development
11.10 HISUN
11.10.1 HISUN Company Details
11.10.2 HISUN Business Overview
11.10.3 HISUN Dactinomycin Introduction
11.10.4 HISUN Revenue in Dactinomycin Business (2016-2021)
11.10.5 HISUN Recent Development
11.11 Hainan Jinrui Pharmaceutical
11.11.1 Hainan Jinrui Pharmaceutical Company Details
11.11.2 Hainan Jinrui Pharmaceutical Business Overview
11.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Introduction
11.11.4 Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2016-2021)
11.11.5 Hainan Jinrui Pharmaceutical Recent Development
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Dactinomycin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Dactinomycin Business (2016-2021)
11.12.5 Qilu Pharmaceutical Recent Development
11.13 Shanghai Zhongke Pharmaceutical
11.13.1 Shanghai Zhongke Pharmaceutical Company Details
11.13.2 Shanghai Zhongke Pharmaceutical Business Overview
11.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Introduction
11.13.4 Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2016-2021)
11.13.5 Shanghai Zhongke Pharmaceutical Recent Development
11.14 Shanghai Xinya Pharmaceutical
11.14.1 Shanghai Xinya Pharmaceutical Company Details
11.14.2 Shanghai Xinya Pharmaceutical Business Overview
11.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Introduction
11.14.4 Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2016-2021)
11.14.5 Shanghai Xinya Pharmaceutical Recent Development
11.15 Nantong Xinhe Biotechnology
11.15.1 Nantong Xinhe Biotechnology Company Details
11.15.2 Nantong Xinhe Biotechnology Business Overview
11.15.3 Nantong Xinhe Biotechnology Dactinomycin Introduction
11.15.4 Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2016-2021)
11.15.5 Nantong Xinhe Biotechnology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Dactinomycin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Implants
Table 4. Global Dactinomycin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dactinomycin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dactinomycin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dactinomycin Market Share by Regions (2016-2021)
Table 8. Global Dactinomycin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dactinomycin Market Share by Regions (2022-2027)
Table 10. Dactinomycin Market Trends
Table 11. Dactinomycin Market Drivers
Table 12. Dactinomycin Market Challenges
Table 13. Dactinomycin Market Restraints
Table 14. Global Dactinomycin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dactinomycin Market Share by Players (2016-2021)
Table 16. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dactinomycin as of 2020)
Table 17. Ranking of Global Top Dactinomycin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dactinomycin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dactinomycin Product Solution and Service
Table 21. Date of Enter into Dactinomycin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dactinomycin Revenue Market Share by Type (2016-2021)
Table 25. Global Dactinomycin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dactinomycin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dactinomycin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dactinomycin Revenue Market Share by Application (2016-2021)
Table 29. Global Dactinomycin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dactinomycin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dactinomycin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dactinomycin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dactinomycin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dactinomycin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dactinomycin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dactinomycin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dactinomycin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dactinomycin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dactinomycin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dactinomycin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dactinomycin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dactinomycin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dactinomycin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dactinomycin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dactinomycin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dactinomycin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dactinomycin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dactinomycin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dactinomycin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dactinomycin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dactinomycin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dactinomycin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dactinomycin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dactinomycin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dactinomycin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dactinomycin Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Dactinomycin Product
Table 64. AstraZeneca Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Dactinomycin Product
Table 69. GSK Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Recordati Rare Diseases Company Details
Table 72. Recordati Rare Diseases Business Overview
Table 73. Recordati Rare Diseases Dactinomycin Product
Table 74. Recordati Rare Diseases Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 75. Recordati Rare Diseases Recent Development
Table 76. Lundbeck Company Details
Table 77. Lundbeck Business Overview
Table 78. Lundbeck Dactinomycin Product
Table 79. Lundbeck Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 80. Lundbeck Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Dactinomycin Product
Table 84. Merck Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Prasco Laboratories Company Details
Table 87. Prasco Laboratories Business Overview
Table 88. Prasco Laboratories Dactinomycin Product
Table 89. Prasco Laboratories Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 90. Prasco Laboratories Recent Development
Table 91. X-GEN Pharmaceuticals Company Details
Table 92. X-GEN Pharmaceuticals Business Overview
Table 93. X-GEN Pharmaceuticals Dactinomycin Product
Table 94. X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 95. X-GEN Pharmaceuticals Recent Development
Table 96. Mylan Institutional Company Details
Table 97. Mylan Institutional Business Overview
Table 98. Mylan Institutional Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 99. Mylan Institutional Recent Development
Table 100. Bedford Pharmaceuticals Company Details
Table 101. Bedford Pharmaceuticals Business Overview
Table 102. Bedford Pharmaceuticals Dactinomycin Product
Table 103. Bedford Pharmaceuticals Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 104. Bedford Pharmaceuticals Recent Development
Table 105. HISUN Company Details
Table 106. HISUN Business Overview
Table 107. HISUN Dactinomycin Product
Table 108. HISUN Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 109. HISUN Recent Development
Table 110. Hainan Jinrui Pharmaceutical Company Details
Table 111. Hainan Jinrui Pharmaceutical Business Overview
Table 112. Hainan Jinrui Pharmaceutical Dactinomycin Product
Table 113. Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 114. Hainan Jinrui Pharmaceutical Recent Development
Table 115. Qilu Pharmaceutical Company Details
Table 116. Qilu Pharmaceutical Business Overview
Table 117. Qilu Pharmaceutical Dactinomycin Product
Table 118. Qilu Pharmaceutical Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 119. Qilu Pharmaceutical Recent Development
Table 120. Shanghai Zhongke Pharmaceutical Company Details
Table 121. Shanghai Zhongke Pharmaceutical Business Overview
Table 122. Shanghai Zhongke Pharmaceutical Dactinomycin Product
Table 123. Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 124. Shanghai Zhongke Pharmaceutical Recent Development
Table 125. Shanghai Xinya Pharmaceutical Company Details
Table 126. Shanghai Xinya Pharmaceutical Business Overview
Table 127. Shanghai Xinya Pharmaceutical Dactinomycin Product
Table 128. Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 129. Shanghai Xinya Pharmaceutical Recent Development
Table 130. Nantong Xinhe Biotechnology Company Details
Table 131. Nantong Xinhe Biotechnology Business Overview
Table 132. Nantong Xinhe Biotechnology Dactinomycin Product
Table 133. Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2016-2021) & (US$ Million)
Table 134. Nantong Xinhe Biotechnology Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dactinomycin Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Implants Features
Figure 4. Global Dactinomycin Market Share by Application: 2020 VS 2027
Figure 5. Alkylating Agent Case Studies
Figure 6. Hormone Case Studies
Figure 7. Plant Medicine Case Studies
Figure 8. Dactinomycin Report Years Considered
Figure 9. Global Dactinomycin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dactinomycin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dactinomycin Market Share by Regions: 2020 VS 2027
Figure 12. Global Dactinomycin Market Share by Regions (2022-2027)
Figure 13. Global Dactinomycin Market Share by Players in 2020
Figure 14. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dactinomycin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dactinomycin Revenue in 2020
Figure 16. Global Dactinomycin Revenue Market Share by Type (2016-2021)
Figure 17. Global Dactinomycin Revenue Market Share by Type (2022-2027)
Figure 18. North America Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dactinomycin Market Share by Type (2016-2027)
Figure 20. North America Dactinomycin Market Share by Application (2016-2027)
Figure 21. North America Dactinomycin Market Share by Country (2016-2027)
Figure 22. United States Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dactinomycin Market Share by Type (2016-2027)
Figure 26. Europe Dactinomycin Market Share by Application (2016-2027)
Figure 27. Europe Dactinomycin Market Share by Country (2016-2027)
Figure 28. Germany Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dactinomycin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dactinomycin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dactinomycin Market Share by Region (2016-2027)
Figure 38. China Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dactinomycin Market Share by Type (2016-2027)
Figure 46. Latin America Dactinomycin Market Share by Application (2016-2027)
Figure 47. Latin America Dactinomycin Market Share by Country (2016-2027)
Figure 48. Mexico Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dactinomycin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dactinomycin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dactinomycin Market Share by Country (2016-2027)
Figure 54. Turkey Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dactinomycin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 58. GSK Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 59. Recordati Rare Diseases Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 60. Lundbeck Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 62. Prasco Laboratories Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 63. X-GEN Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 64. Mylan Institutional Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 65. Bedford Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 66. HISUN Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 67. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 68. Qilu Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 69. Shanghai Zhongke Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 70. Shanghai Xinya Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 71. Nantong Xinhe Biotechnology Revenue Growth Rate in Dactinomycin Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のヒト成長ホルモン（hGH）市場規模・現状・予測（2021年-2027年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…- 世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
- 世界の人工内耳市場規模・現状・予測（2021年-2027年） Hearing implants are an option when conventional hearing aids no longer give enough benefit. Implants are designed for different types of hearing loss. They are surgically implanted devices which can give you the sensation of sound. The increasing prevalence of hearing loss as one of the primary fac…
- 世界のホルモンペレット療法市場規模・現状・予測（2021年-2027年） Hormone Pellet Therapy is a method using man-made hormones to replace hormones produced by human body. Market Analysis and Insights: Global Hormone Pellet Therapy Market The global Hormone Pellet Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR…
- 世界の腎芽腫治療市場規模・現状・予測（2021年-2027年） Nephroblastoma is a cancer of the kidneys that typically occurs in children, rarely in adults. Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occurs in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly respo…